UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Raising Regulatory Risks for Tech Firms
Goldman Sachs CD Offering at 4 Outpaces Average Bank Rates
Italy Stocks End Lower as Investingcom Italy 40 Declines 076
PepsiCo Reportedly Preparing Snack Price Hikes for Late June
Borosil Glass Works Shares Triple Over Past Year on Strong Revenue and EBITDA Growth
CNBC Team Trims Stock After 46 Weekly Surge Citing Parabolic Move ProfitTaking Strategy
The9 Limited NCTY Q1 2012 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid Revenue Uncertainty
BHFAL Q1 2026 Earnings Earnings Miss Estimates Amid Market Challenges
ELBM Q4 2025 Earnings Significant EPS Miss as PreRevenue Company Navigates Development Phase
WEN Q1 2026 Earnings EPS Surpasses Estimates by 241 as Value Initiatives Drive Profitability
Lunai Bioworks Inc LNAI Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Amid Pipeline Progress
Caleres Q1 2026 Earnings EPS Surprises to the Upside Despite Loss Shares Rally
CDT Equity Inc Warrant CDTTW Holds at 001 A Penny Stock at a Trading Crossroads
STAAR Surgical Stock Edges Lower Amid Consolidation Near Key Support Levels
Cathay General Bancorp CATY Posts Modest Gain Holds Above Key Support
Nathans Famous NATH Holds Near 101 as RangeBound Trading Persists
Hanover Insurance Group THG Retreats 2 as Insurance Sector Faces Renewed Pressure
Surprising Shift in Alphabets Portfolio CME Group Ousts AST SpaceMobile as Top Holding
SBI Strike Alert State Bank of India Branches May Face Disruption on May 2526
China Emerges as Leading Competitor in Humanoid Robot Workforce Integration Says Tesla CEO
America Movil Targets Steady Growth Maintains 7 Billion Capex Plan
China Boosts Coal Reserves to 30Day Supply as El Nino Threat Looms
Markets Brace for Trio of Economic Releases GDP Revision PCE Inflation and Oil Inventories on May 28
SpaceX IPO Speculation Nvidia Earnings Bezos AI Bubble Comments Lead Morning Market Briefing
Expion360 Q2 2025 Earnings EPS Beats Estimates by 307 Amid Cost Discipline
Revelation Biosciences REVB Consolidates Near Key Support at 103